Literature DB >> 14531762

Psychotic disorder in a case with Hallervorden-Spatz disease.

O Oner1, P Oner, G Deda, D Içağasioğlu.   

Abstract

OBJECTIVE: Hallervorden-Spatz disease is a rare autosomal recessive condition, with early onset of predominantly extrapyramidal dysfunction. The symptoms of the disease are dystonia, rigidity, choreoathetosis, pyramidal signs, and intellectual decline. Recent genetic studies mapped the disease to chromosome 20p12.3-p13, and identified mutations in the pantothenate kinase gene. This report describes a childhood onset case of Hallervorden-Spatz disease with schizophreniform psychotic symptoms. Former reports about the psychiatric comorbidity generally included depressive disorder.
METHOD: A single case report.
RESULTS: A 14-year-old boy with Hallervorden-Spatz disease presented a psychotic episode with prominent auditory hallucinations. Symptoms were relieved after neuroleptic treatment.
CONCLUSION: To the authors' knowledge, this is the first published report of the disease with psychotic symptoms. The contribution of basal ganglia, with their wide projections, to the emergence of psychotic symptoms was discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531762     DOI: 10.1034/j.1600-0447.2003.00159.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Conversion disorder as initial diagnosis in pantothenate kinase associated neurodegeneration.

Authors:  I Vansteenkiste; W A van Gool; D J Hofstee; Marina A J Tijssen
Journal:  J Neurol       Date:  2010-08-18       Impact factor: 4.849

Review 2.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

3.  Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.

Authors:  A Li; R Paudel; R Johnson; R Courtney; A J Lees; J L Holton; J Hardy; T Revesz; H Houlden
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

4.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

5.  A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia.

Authors:  Yogesh Pawar; Gurvinder Kalra; Sushma Sonavane; Nilesh Shah
Journal:  Indian J Psychiatry       Date:  2013-10       Impact factor: 1.759

6.  Late onset atypical pantothenate-kinase-associated neurodegeneration.

Authors:  Natalie Diaz
Journal:  Case Rep Neurol Med       Date:  2013-03-24

7.  Psychiatric disorder in two siblings with hallervorden-spatz disease.

Authors:  Young-Kyung Sunwoo; Jeong-Seop Lee; Won-Hyoung Kim; Yong-Bum Shin; Myung-Ji Lee; In-Hee Cho; Sun-Myeong Ock
Journal:  Psychiatry Investig       Date:  2009-08-03       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.